Alpha Ascent Organelle LLC
Alpha Ascent Organelle LLC is a venture capital fund based in Philadelphia, Pennsylvania. According to its most recent Form D, filed Dec 15, 2022, it has sold $2,000,000 of interests to 17 investors since its first sale in Dec 2022. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Alpha Ascent Ventures LLC; Eric Greenberg; Alpha Ascent Organelle Manager LLC.
- Total raised
- $2,000,000Cumulative sales reported on Form D
- Investors
- 17
- First sale
- Dec 13, 2022
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Alpha Ascent Ventures LLC; Eric Greenberg; Alpha Ascent Organelle Manager LLC
- Latest Form D
- Dec 15, 2022
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Alpha Ascent Organelle LLC
What is the minimum investment for Alpha Ascent Organelle LLC?
Alpha Ascent Organelle LLC's latest Form D, filed Dec 15, 2022, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Alpha Ascent Organelle LLC?
Alpha Ascent Organelle LLC is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Alpha Ascent Organelle LLC raised?
Alpha Ascent Organelle LLC reports $2,000,000 sold from 17 investors on its Form D filed Dec 15, 2022. This is cumulative sales since the offering began, not current assets or performance.
Where is Alpha Ascent Organelle LLC based?
Alpha Ascent Organelle LLC is based in Philadelphia, Pennsylvania.
When did Alpha Ascent Organelle LLC launch?
Alpha Ascent Organelle LLC reports its first sale in Dec 2022.
Size compared with every venture capital fund
Raised more than 62% of the 76 venture capital funds based in Pennsylvania, and more than 70% of all 14,901 that report sales.